SEC Form 4 · accession 0000950138-16-001365
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melvin D Booth
Director
Period of report
Oct 1, 2016
Accepted (ET)
Oct 4, 2016 · 8:48 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Oct 1, 2016 | A | 1,057 | $0.00 | A | 8,146 | D | |
| Ordinary Shares | holding | — | — | — | 19,381 | I | By Melvin D. Booth Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units that vest in their entirety as of October 1, 2017. The restricted stock units settle in ordinary shares upon vesting.